Daily Archives: April 21, 2017

StockNewsJournal

Analyst's Predictions on CF Industries Holdings, Inc. (CF), MEDNAX, Inc. (MD) StockNewsJournal Investors who are keeping close eye on the stock of CF Industries Holdings, Inc. (NYSE:CF) established that the company was able to keep return on investment at -1.41 in the trailing twelve month while Reuters data showed that industry's average stands ... Analysts See $0.06 EPS for CF Industries Holdings, Inc. (CF); Outfront Media (OUT) SI Increased By 35.2%Wolcott Daily CF Industries Holdings, Inc. (CF) Receives $32.25 Average Target Price from BrokeragesMarkets Daily CF Industries Holdings, Inc. (CF) Price Target Cut to $26.00The Cerbat Gem The Newburgh Press -Transcript Daily -Free Observer all 61 news articles »

Read the original here:

Analyst's Predictions on CF Industries Holdings, Inc. (CF), MEDNAX, Inc. (MD) - StockNewsJournal

ATLANTA--(BUSINESS WIRE)--

CF Real Estate Services is pleased to announce that Tom Lamberth has been named regional partner. In addition to leading operations in Texas and Louisiana for the growing multifamily real estate firm, Lamberth will also be growing the companys presence through select opportunities in the Southwest.

We are very excited to have Tom join CF Real Estate Services, said Byron Cocke, co-CEO. Tom is a high-caliber individual with a stellar track record of performance in both property management and investment. We are looking to continue that track record with our new partnership at CF Real Estate Services.

In his new role, Lamberth will leverage his extensive background to expand the companys platform in development, acquisitions and third party property management services in Texas, Louisiana and surrounding markets, and will lead a team of top real estate professionals in the companys new regional office in Dallas.

Prior to joining CF Real Estate Services, Lamberth served as vice president at UDR for 15 years, where he was responsible for development activities in Texas and other select markets, including Washington, D.C.; North Carolina; Florida; and Arizona. His experience in the Dallas-Fort Worth area includes the assemblage, entitlement and development of Vitruvian Park in Addison, a 125-acre, urban master-planned, mixed-use development that will have 6,000 units when completed. Lamberth also served as an area director for UDR, heading the operations of 12,000 homes in markets throughout the Southeast and Mid-Atlantic. Prior to his tenure with UDR, Lamberth held senior-level positions with Lincoln Property Company, where, as senior vice president, he co-directed the operations of 42,000 apartment homes in the eastern U.S.

Headquartered in Atlanta, GA, CF Real Estate Services is a vertically integrated multifamily real estate firm. With decades of multifamily industry experience, the team has evolved into a leading provider of multifamily services including property management, asset management, and consulting. CF Real Estate Services serves clients in 14 states. With expertise in affordable, conventional and student housing, CF Real Estate Services successfully manages various holdings in multiple arenas of real estate.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170420005167/en/

Read more here:

Lamberth Named Regional Partner for CF Real Estate Services - Yahoo Finance

Crowdfunding, as allowed by Reg CF (created by Title III of the JOBS Act) was designed to improve access to capital for smaller firms in need of funding while providing new investment opportunities for smaller investors. For too many years the little guy has been boxed out from access to capital and early stage investments, so the story goes.

Oceans of money flowed into hotbeds of startup centers like Silicon Valley or Alley, but if youre not located in those epicenters, youre our of luck. Sorry. And if you were not a hotshot investor, well good luck.

Reg CF launched in May of 2016 with a decent amount of fanfare and a fair amount of optimism. Finally, the internet was going to democratize access to capital. It was about time.

But in the ensuing months, did this, in fact, occur? Good question.

Several weeks back, there was a closed meeting that involved members of the Securities and Exchange Commission (SEC), representatives from the North American Securities Administrators Association (NASAA) and other crowdfunding participants including several prominent platforms. The meeting was not open to press so (as far as I am aware) all proceedings were rather hush-hush. But several participants have spoken with representatives from Crowdfund Insider sharing a more dystopic view of the emerging Reg CF ecosystem.

One informed individual told Crowdfund Insider the sentiment was that the wheels have fallen off of Reg CF crowdfunding as the exemption has not lived up to the hype.

And why would this be? The challenges have to do with the highly prescriptive nature of Reg CF. The rules, designed to protect investors, may be doing just the opposite as very high quality firms do not want to pay the associated costs nor file all of the mandated disclosures. Using Reg D is far simpler and economical.

These litany of complaints are issues that several members of Congress have attempted to address. Most prominently, Congressman Patrick McHenry, the tenacious policymaker who has always been looking out for the little guy.

Yet time and again, his efforts to improve upon the existing Reg CF rules have been cut short, stymied by a perplexing group of malcontents and disbelievers. McHenrys office did not participate in the NASAA / SEC powwow but that should not come as a surprise. Why would you invite someone who wants to fix what is broken?

Speaking with one individual with knowledge of the event, they explained;

The general consensus was that Reg CF was totally dysfunctional. The NASAA representatives were pushing the low quality of the [crowdfunding] deals. Market participants were pointing to the compliance costs and the challenges intrinsic to Reg CF. There was disagreement as to why the exemption was not being adopted more broadly.

This individual said that NASAA was firmly entrenched with the belief that Reg CF does not exempt them from state compliance, even though that was the intent of Congress. This person said NASAA hates it.

They [NASAA] absolutely want to keep control over [securities] issuance They would love to see it go away. They are happy with the current state of affairs.

The thesis is that NASAA, a special interest group, wants issuers to use intrastate crowdfunding exemptions instead of a federal exemptions. NASAA is attempting to push Reg CF into obscurity so that companies looking to raise capital are compelled to go directly to the state. This is a question of state authority, power and money. This is a story of politics. Unfortunately the early stage company gets lost in this equation. Steamrolled by parochial politics.

Interestingly, the same individual said the SEC was more open to supporting Reg CF. Apparently, the Commission has been relieved to see that no cascade of fraud has taken place and they WANT Reg CF to be successful, recognizing the importance of capital formation for smaller firms. The SEC may even be inclined to revisit the exemption and do what they can to fix it. There was an overall willingness in the room to see crowdfunding as viable.

In NASAAs defense, the insider described NASAAs leadership as not completely indicative of member support. Many state regulators are more supportive than NASAA executives recognizing that economic need should trump small-minded politics. No one wants to remove NASAAs ability to enforce anti-fraud laws. But creating an ecosystem where issuers must kiss the ring and pay the toll of 50 states just doesnt make sense.

While there may never be clearcut unanimity on what must be done to improve the Reg CF exemption, many industry participants believe McHenrys first Fix Crowdfunding Act covered most all of the bases. Still, crowdfunding platforms continue to use the exemption with a certain amount of success. In nearly a year, almost $24 million has been raised to support entrepreneurial firms. But still more could be done as that is just a drop in the bucket.

Speaking with Kendrick Nguyen, co-founder and CEO of Republic, a mission driven crowdfunding platform that did not participate in the NASAA/SEC gathering, Nguyen believes that education and broad based information is mainly to blame;

I am not certain the concerns about the industry traction should be blamed on the SEC. Much of it is about investor education. This is something that can be simple and effective but people are unaware of it.

That being said, Nguyen acknowledges that simple improvements could easily be made to boost SME utilization;

The $1 million cap is not worth it for tech companies. $5 million would be nice. Accounting requirements and the ongoing reporting is the toughest thing for us. Companies that are most attractive to investors do not want to share their financials.

So where do we go now?

There is a Congressional push to help SMEs gain better access to capital but hurdles remain. Most elected officials have never started a company nor had to make payroll so there is a formative gap as to what it really takes. Special interest groups continue to pound the drum of investor protection to buttress their own opinions minus any actual data proving out pure speculation. While solutions to improving the crowdfunding ecosystem may seem simple to small business advocates, in our nations capital, political reality just delivers more regulatory challenges.

.

View post:

Have the Wheels Fallen Off of Reg CF Crowdfunding? - Crowdfund Insider

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

ContraFect Corporation (NASDAQ: CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for life-threatening, drug-resistant infectious diseases, today announces the presentation of new data from its Phase 1 CF-301 study at the 27th European Congress of Clinical Microbiology and Infectious Disease (ECCMID) to be held on April 22-25, 2017 in Vienna, Austria.

ContraFect's lead compound, CF-301 is a first-in-class lysin which has demonstrated a rapid and potent ability to kill Staphylococcus aureus (Staph aureus) bacteria in vitro and in animal studies. CF-301 is currently in development for the treatment of bacteremia due to Staph aureus, including methicillin resistant strains (MRSA). Initial results from the Phase 1, first-in-human study of CF-301 in healthy volunteers, which were presented in a late breaker presentation at ECCMID 2016, showed CF-301 to be well-tolerated with no clinical adverse safety signals. This year, long term follow-up data from this Phase 1 trial will be presented at ECCMID. In addition, a newly developed methodology for testing the susceptibility of Staph aureus bacteria to CF-301 in clinical settings will be presented.

"We are pleased to return to ECCMID, where we will present additional six-month follow up results from the initial Phase 1 study which extend our understanding of the safety profile of CF-301 and the timeframe for the resolution of anti-drug antibodies. We are also presenting a new methodology for CF-301 susceptibility testing, which has been optimized for use in clinical testing laboratories and which will be used in our upcoming Phase 2 study," said Cara Cassino, M.D., EVP of Research and Development and Chief Medical Officer at ContraFect.

Presentation Details:

Presentation Title: Long-Term Immunology Follow-up Results of a Phase 1 Placebo Controlled Dose Escalating Study to Examine the Safety of Intravenous Doses of CF-301 In Human Subjects Session Day & Time: Saturday, April 22, 2017, 3:30p - 4:30p CET (10:30a-11:30a ET) Abstract Number: 7121 Session Title: Phages and Phage Products

Presentation Title: Development of an Antimicrobial Susceptibility Test (AST) for the Antistaphylococcal Lysin CF-301 Session Day & Time: Saturday, April 22, 2017, 08:45a - 3:30p CET (3:45a-10:30a ET) E-poster number: EV0038 Abstract Number: 6193 Session Title: Bacterial Susceptibility & Resistance

The abstracts can be accessed through the ECCMID website. Following the meeting, the presentation posters will be available on the ContraFect Corporation website.

Continue reading here:

ContraFect (CFRX) to Present New Data from CF-301 Study at ECCMID - StreetInsider.com